{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:29:00Z","timestamp":1790713740575,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Aage og Johanne Louis-Hansen Fonden","award":["25-2B-17398"],"award-info":[{"award-number":["25-2B-17398"]}]},{"name":"AP M\u00f8ller Fonden","award":["2024-00941"],"award-info":[{"award-number":["2024-00941"]}]},{"name":"Overl\u00e6ger\u00e5dets forskningsfond Odense Universitetshospital","award":["j nr 167-A6420"],"award-info":[{"award-number":["j nr 167-A6420"]}]},{"name":"Beckett-Fondation","award":["25-2-14395"],"award-info":[{"award-number":["25-2-14395"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Importance and Objective<\/jats:title>\n                    <jats:p>Chronic opioid use may increase the risk of complications in patients with inflammatory bowel disease (IBD). Rheumatologic illness has been identified as a risk factor for chronic opioid use in IBD, but the specific influence of spondyloarthritis (SpA) on this risk is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This nationwide cohort study included adults diagnosed with Crohn\u2019s disease (CD) or ulcerative colitis (UC) between 1999 and 2021 in Denmark.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>We compared IBD patients with SpA diagnosed within 3\u2009years before or after the IBD diagnosis (ie IBD+SpA) and IBD patients without SpA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was chronic opioid use \u22643\u2009years after IBD diagnosis, defined as \u22653 opioid prescriptions \u22651\u2009month apart within a 12-month period. Using multivariable logistic regression, we determined the association of SpA with chronic opioid use while adjusting for age, sex, IBD type, year of IBD diagnosis, Charlson comorbidity index, and psychotropic medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 45 172 patients diagnosed with IBD between 1999 and 2021, among which 666 had IBD+SpA. Chronic opioid use occurred in 20.4% of IBD+SpA versus 9.8% of IBD-only patients. SpA was associated with increased odds of chronic opioid use (adjusted odds ratio 2.78, 95% confidence interval, 2.26-3.42). Similar associations were seen across IBD+axial or peripheral SpA, UC+SpA, and CD+SpA subgroups as well as a sub-analysis of chronic use of only strong opioids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this nationwide cohort, SpA was strongly associated with chronic opioid use in patients diagnosed with IBD. These findings highlight IBD+SpA as a high-risk phenotype warranting early identification and multidisciplinary pain management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izaf281","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:01:25Z","timestamp":1763139685000},"page":"688-694","source":"Crossref","is-referenced-by-count":2,"title":["Association of Spondyloarthritis With Chronic Opioid Use in Inflammatory Bowel Disease: A Nationwide Danish Cohort Study"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-8441","authenticated-orcid":false,"given":"Rahul S","family":"Dalal","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA 02215,","place":["United States"]},{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Erichsen","family":"Zeiss","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7634-6812","authenticated-orcid":false,"given":"Jan","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Dyrl\u00f8v","family":"Madsen","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Ermann","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Inflammation and Immunity, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-3033","authenticated-orcid":false,"given":"Bente Mertz","family":"N\u00f8rg\u00e5rd","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"2026040214064146300_izaf281-B1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/07853890.2016.1195011","article-title":"Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases","volume":"48","author":"Col\u00eca","year":"2016","journal-title":"Ann Med"},{"key":"2026040214064146300_izaf281-B2","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2026040214064146300_izaf281-B3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2017.10.022","article-title":"Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England","volume":"16","author":"Burr","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026040214064146300_izaf281-B4","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/ajg.2014.230","article-title":"The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis","volume":"109","author":"Targownik","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2026040214064146300_izaf281-B5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cgh.2020.08.041","article-title":"Opioid use among patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Blake","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026040214064146300_izaf281-B6","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003353","article-title":"Predictors for chronic opioid use in patients with inflammatory bowel disease\u2014a population based cohort study","author":"N\u00f8rg\u00e5rd","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"2026040214064146300_izaf281-B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3899\/jrheum.150628","article-title":"Inflammatory bowel diseases and spondyloarthropathies","volume":"93","author":"Gionchetti","year":"2015","journal-title":"J Rheumatol Suppl"},{"key":"2026040214064146300_izaf281-B8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/annrheumdis-2019-216516","article-title":"What is axial spondyloarthritis? A latent class and transition analysis in the SPACE and DESIR cohorts","volume":"79","author":"Sepriano","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2026040214064146300_izaf281-B9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00296-005-0044-9","article-title":"The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease","volume":"26","author":"Turkcapar","year":"2006","journal-title":"Rheumatol Int"},{"key":"2026040214064146300_izaf281-B10","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3748\/wjg.15.2449","article-title":"Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease","volume":"15","author":"Salvarani","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2026040214064146300_izaf281-B11","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.14309\/ajg.0000000000003292","article-title":"Prevalence and risk factors of spondyloarthritis symptoms in a US-based multicenter cohort of patients with inflammatory bowel disease","volume":"120","author":"Hong","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"2026040214064146300_izaf281-B12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.crohns.2009.11.005","article-title":"The joint\u2013gut axis in inflammatory bowel diseases","volume":"4","author":"Brakenhoff","year":"2010","journal-title":"J Crohns Colitis"},{"key":"2026040214064146300_izaf281-B13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/rheumatology\/ken176","article-title":"Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration","volume":"47","author":"Stone","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2026040214064146300_izaf281-B14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/rheumatology\/kep435","article-title":"Frequency and characteristics of disease flares in ankylosing spondylitis","volume":"49","author":"Cooksey","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2026040214064146300_izaf281-B15","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kev015","article-title":"Severe flare as a predictor of poor outcome in ankylosing spondylitis: a cohort study using questionnaire and routine data linkage","volume":"54","author":"Cooksey","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2026040214064146300_izaf281-B16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3899\/jrheum.160838","article-title":"Patient-reported flares in ankylosing spondylitis: a cross-sectional analysis of 234 patients","volume":"44","author":"Jacquemin","year":"2017","journal-title":"J Rheumatol"},{"key":"2026040214064146300_izaf281-B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026040214064146300_izaf281-B18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"key":"2026040214064146300_izaf281-B19","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/ije\/dyw213","article-title":"Data resource profile: The Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2026040214064146300_izaf281-B20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2026040214064146300_izaf281-B21","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/ibd\/izy222","article-title":"Starting young: trends in opioid therapy among US Adolescents and young adults with inflammatory bowel disease in the Truven MarketScan Database between 2007 and 2015","volume":"24","author":"Wren","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2026040214064146300_izaf281-B22","doi-asserted-by":"publisher","first-page":"101870","DOI":"10.1016\/j.berh.2023.101870","article-title":"Diagnostic delay in axial spondylarthritis: a lost battle?","volume":"37","author":"Barnett","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2026040214064146300_izaf281-B23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/ecco-jcc\/jjac065","article-title":"Association between inflammatory bowel disease and spondyloarthritis: findings from a nationwide study in Sweden","volume":"16","author":"Shrestha","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026040214064146300_izaf281-B24","doi-asserted-by":"publisher","first-page":"e039238","DOI":"10.1136\/bmjopen-2020-039238","article-title":"Risk factors for new chronic opioid use after hip fracture surgery: a Danish nationwide cohort study from 2005 to 2016 using the Danish multidisciplinary hip fracture registry","volume":"11","author":"Edwards","year":"2021","journal-title":"BMJ Open"},{"key":"2026040214064146300_izaf281-B25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40801-019-00163-w","article-title":"Trends of opioid utilisation in \u00adDenmark: a nationwide study","volume":"6","author":"Nissen","year":"2019","journal-title":"Drugs Real World Outcomes"},{"key":"2026040214064146300_izaf281-B26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/apt.18014","article-title":"The use of opioids nine months after surgery for Crohn\u2019s disease\u2014a nationwide cohort study","volume":"60","author":"N\u00f8rg\u00e5rd","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"2026040214064146300_izaf281-B27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2147\/CLEP.S509147","article-title":"Mental disorders in Danish Hospital Registers: a review of content and possibilities for epidemiological research","volume":"17","author":"Plana-Ripoll","year":"2025","journal-title":"Clin Epidemiol"},{"key":"2026040214064146300_izaf281-B28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026040214064146300_izaf281-B29","doi-asserted-by":"publisher","first-page":"323","DOI":"10.14309\/ajg.0000000000002497","article-title":"Older adult-onset of inflammatory bowel diseases is associated with higher utilization of analgesics: a nationwide cohort study","volume":"119","author":"Dalal","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2026040214064146300_izaf281-B30","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2026040214064146300_izaf281-B31","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1007\/s10620-025-09016-9","article-title":"Musculoskeletal symptoms and clinical findings in bio-na\u00efve patients with inflammatory bowel disease prior to biological treatment initiation: a prospective cohort study","volume":"70","author":"Vladimirova","year":"2025","journal-title":"Dig Dis Sci"},{"key":"2026040214064146300_izaf281-B32","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s10067-022-06100-7","article-title":"Diagnostic delay in axial spondyloarthritis: a systematic review","volume":"41","author":"Hay","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2026040214064146300_izaf281-B33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1155\/2013\/139702","article-title":"Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease","volume":"27","author":"Stolwijk","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"2026040214064146300_izaf281-B34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3109\/03009742.2015.1010572","article-title":"Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register","volume":"44","author":"Lindstr\u00f6m","year":"2015","journal-title":"Scand J Rheumatol"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/4\/688\/65291890\/izaf281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/4\/688\/65291890\/izaf281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:06:47Z","timestamp":1775153207000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/4\/688\/8323434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,11,14]]},"published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf281","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,11,14]]}}}